budesonide

(redirected from Pulmicort Respules)
Also found in: Medical.
Translations
budesonid

budesonide

n budesonida, budesónida (INN)
References in periodicals archive ?
The decision by the court in New Jersey as well ruled that AstraZeneca's request for a permanent injunction is refused, opening the way for Actavis' copy of Pulmicort Respules (budesonide) as it does not infringe the 834 patent .
AstraZeneca also announced that a US federal appeals court had issued a temporary injunction blocking generic manufacturers from distributing versions of Pulmicort Respules, an asthma treatment.
AstraZeneca has full confidence in the strength of its intellectual property rights protecting Pulmicort Respules.
Generic competition for Pulmicort Respules for asthma and Toprol-XL blood-pressure treatment also hurt sales.
The London-based company made the decision based in part on new generic competition against asthma drug Pulmicort Respules, which is manufactured in Westboro.
from launching a generic version of AstraZeneca's PULMICORT RESPULES (budesonide inhalation suspension) in the US.
The launch of a generic version of Mirapex and continued strong sales from existing products like generic versions of Pulmicort Respules, Adderall XR, Accutane, and Eloxatin helped North American revenues grow 20% to $2,309 million.
17, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States Court of Appeals for the Federal Circuit has issued a temporary injunction to prevent Actavis from further distribution of its generic version of Pulmicort RESPULES (budesonide inhalation suspension) 0.
Weston, Ontario) from selling a generic version of AstraZeneca Plc's lucrative Pulmicort Respules asthma medicine prior to a patent infringement trial, the British drugmaker said.
The Turbuhaler delivers 200 micrograms/metered dose, whereas Pulmicort Respules is available in doses of 0.
Toronto, Canada) from selling copies of the asthma drug Pulmicort Respules.
Mode of Action 79 Approvals 79 Patents 79 Generic Company Activity 80 Market Outlook 80 GENERIC COMPETITORS 82 Actavis 82 Respiratory Market Presence 82 Budesonide 82 Levalbuterol 83 Apotex 84 Respiratory Market Presence 84 Azelastine Hydrochloride 84 Pulmicort Respules (budesonide) Litigation 84 Cipla 85 Respiratory Market Presence 85 Mylan 86